O-acetylation is a common modification of bacterial glycoconjugates. By modifying oligosaccharide structure and chemistry, O-acetylation has important consequences for biotic and abiotic recognition events and thus bacterial fitness in general. Previous studies of the broad-spectrum O-linked protein glycosylation in pathogenic Neisseria species (including N. gonorrhoeae and N. meningitidis) have revealed O-acetylation of some of their diverse glycoforms and identified the committed acetylase, PglI. Herein, we extend these observations by using mass spectrometry to examine a complete set of all glycan variants identified to date. Regardless of composition, all glycoforms and all sugars in the oligosaccharide are subject to acetylation in a PglI-dependent fashion with the only exception of di-N-acetyl-bacillosamine. Moreover, multiple sugars in a single oligosaccharide could be simultaneously modified. Interestingly, O-acetylation status was found to be correlated with altered chain lengths of oligosaccharides expressed in otherwise isogenic backgrounds. Models for how this unprecedented phenomenon might arise are discussed with some having potentially important implications for the membrane topology of glycan O-acetylation. Together, the findings provide better insight into how O-acetylation can both directly and indirectly govern glycoform structure and diversity.
Introduction
Bacterial extracytoplasmic glycoconjugates such as peptidoglycan (PG), capsular polysaccharides (CPS), exopolysaccharides and lipopolysaccharide/lipoologosaccharides (LPS/LOS) play important and influential roles in the fitness of microbes within diverse environments. As in many other biological systems, glycan diversity in these extracytoplasmic glycoconjugates is generated by the use of a vast array of unique monosaccharides linked in linear and branched chains with varying stereochemistry and configurations. These structures can be further elaborated by enzyme-mediated chemical modifications including methylation, sulfation, phosphorylation, acylation and epimerization as well as by the covalent addition of amino acids (Varki et al. 2009 ). One chemical modification that is particularly widespread among bacterial glycoconjugates is O-acetylation. This modification occurs at free hydroxyl groups on sugar residues and is mediated by O-acetyltransferase enzymes (Clarke et al. 2000) . Some bacterial systems also make use of esterases that O-deacetylate glycoforms leading to dynamic levels of modification. The latter phenomenon is exemplified by the PG remodeling documented in many species (Moynihan and Clarke 2010) .
Two species of pathogenic Neisseria (Neisseria gonorrhoeae (Ng) and Neisseria meningitidis (Nm)) have proven to be interesting models to study glycoconjugate O-acetylation as they have multiple, dedicated O-acetylation systems targeting PG, LOS, and in the case of Nm, CPS (Antignac et al. 2003; Gudlavalleti et al. 2004; Kahler et al. 2006) . Both species also express highly related, broad-spectrum Olinked protein glycosylation (pgl) systems in which some glycoforms are subject to O-acetylation (Aas et al. 2007 ). Glycan biosynthesis, modification and transfer to protein have been examined at both the genetic and biochemical levels in these species (Aas et al. 2007; Vik et al. 2009; Børud et al. 2010 Børud et al. , 2011 . The pgl core locus products act in the synthesis of undecaprenyl diphosphate (UndPP) linked monosaccharides (PglB, PglC and PglD) and its flipping into the periplasm (PglF). PglB acts a bifunctional protein with an acetyltransferase domain and a phospho-glycosyltransferase domain responsible for synthesis of UndPP-N, N′-diacetylbacillosamine (diNAcBac) . Interestingly, nearly one half of Nm isolates express a variant allele of pglB, designated pglB2, with an ATP grasp domain and a phospho-glycosyltransferase domain responsible for synthesis of UndPP-glyceramido-acetamido trideoxyhexose (GATDH) (Kahler et al. 2001; Power et al. 2003 , Chamot-Rooke et al. 2007 . PglA is a galactosyltransferase that extends both UndPP-monosaccharides (diNAcBac and GATDH-based), whereas PglE is a galactosyltransferase that further elaborates the PglA-generated UndPP-linked disaccharide to a trisaccharide (illustrated in Figure 1 ).
In addition to that involving pglB/B2, another significant polymorphism at the core pgl locus involves the variable presence of the pglH gene that lies between the pglF and pglB/B2 genes. It encodes a glucosyltransferase that acts on UndPP-monosaccharides (both diNAcBac and GATDH-based) to generate glucose (Glc)-containing disaccharides (Kahler et al. 2001; Power et al. 2003; Børud et al. 2011 ). An allelic variant of pglH, termed pglH2, results in incorporation of an N-acetylglucosamine (GlcNAc) instead of Glc. In strains simultaneously expressing PglA and PglH, mixtures of Gal-and Glccontaining disaccharides are observed (Børud et al. 2014) . In contrast to the situation with pglA, the pglH-derived UndPP-disaccharide is recalcitrant to further elaboration by PglE. Some strains of Ng and Nm display intrastrain glycan length variation (microheterogeneity) that results from phase-variable, slipped-strand mispairing events within the pglA, pglE and pglH/H2 genes (Power et al. 2003; Aas et al. 2007; Børud et al. 2011 ). In addition, some strains display glycan microheterogeneity due to hypomorphic pglA alleles as well as recoding within pglA that are associated with shifting glycosyltransferase activity (Johannessen et al. 2012) . In summary, individual strains of Ng and Nm have the ability to express arrays of multiple glycans sequentially and simultaneously due to phase variation, recoding and hypomorphic glycosyltransferase alleles. Interstrain glycan differences result from the same processes in addition to differences in glycosyltransferase gene content and status.
Bacterial glycoconjugate O-acetylation requires a member of a broad family of acetyltransferases using acetyl-CoA as a donor precursor. In the case of neisserial pgl-associated glycans, this process is mediated by PglI that it structurally related to O-acetyltransferases modifying LPS in Gram negatives (Slauch et al. 1996; Warren et al. 2004 , Aas et al. 2007 . Shared structural features within these family members include a conserved N-terminal domain with multiple membrane spanning domains (Pfam_PF01757). Comparative MSbased analyses of pgl glycans from wt and pglI mutants demonstrated the role of PglI in O-acetylation (Aas et al. 2007; Børud et al. 2011) . Interestingly, pglI is predicted to be subject to phasevariable expression in Nm but not in Ng. The functional implications of pgl oligosaccharide O-acetylation remain undefined. However, O-acetylation has been shown to alter pgl glycan antigenicity as shown by both immunoblotting and immunogold labeling with glycoform specific mAbs. Those results indicated that O-acetylation masks epitopes present on sugar moieties (Børud et al. 2010) .
There remain some discrepancies in the literature as to the role of pglI. Warren et al. originally concluded that PglI was involved in the biosynthesis of the basal diNAcBac residue (Warren et al. 2004 ). In contrast, MS-based studies found no role for PglI in diNAcBac synthesis but showed that modifications were limited to distal sugars in di-and trisaccharide glycoforms (Aas et al. 2007; Børud et al. 2011 Børud et al. , 2014 .
Here, we examined the effects of O-acetylation on pgl glycan structure in further detail and report a unique association between O-acetylation status and glycoform chain length as well as microheterogeneity. These findings have potentially important implications for the mechanisms by which O-acetylases affect oligosaccharide structure and expression. modified forms ( Figure 2A ). As previously shown (Aas et al. 2007) , the mature form of the PilE protein (processed, methylated and with a single disulfide bond) appear in the spectrum at m/z 17,177.9. The species appearing at m/z 17,300.9 and m/z 17,423.9 correspond to protein modified with one or two phosphoethanolamine (PE) moieties (mass addition of 123.0 Da), respectively (Hegge et al. 2004 Fig. 1a ) detected demonstrating that the second 42 Da mass addition was associated with the glycan modification. Consequently, we used in-source fragmentation of the purified PilE protein ( Figure 2B ) and targeted the reporter ion appearing at m/z 475.2, corresponding to the [H] + reporter ion of the novel 474.2 Da modification, for CID/HCD fragmentation (MS2) coupled with high resolution fragment ion detection analysis. The MS2 spectrum of the ion at m/z 475.2 ( Figure 2E ) showed the same general fragmentation pattern as previously described for diNAcBac-Gal at m/z 391.2 ( Figure 2C ) and diNAcBac-AcGal at m/z 433.2 ( Figure 2D ) (Aas et al. 2007 ). In addition to the loss of water (18.0 Da), commonly experienced in glycan MS fragmentation, fragmentation of the m/z 475.2 ion showed a complete loss of the modified distal Gal to the reporter ions associated with the complete reducing end diNAcBac at m/z 229.1 (diNAcBac fragment ions, Supplementary data, Fig. 1e or Aas et al. 2007) , demonstrating that the new PilE mass addition was a diNAcBac-based disaccharide. Moreover, no ion at m/z 475.2 was detected in the pglA mutant strain (KS141) (Supplementary data, Fig. 1c ), demonstrating that the new mass addition was located on the distal Gal sugar of the protein attached glycan. The high mass accuracy afforded by the Orbitrap showed that the mass addition (42.009 Da) to the distal Gal was nearly exactly the theoretical mass of an acetylation (42.011 Da) (i.e., the mass difference between the precursor glycan ions at m/z 475.190 and m/z 433.181 seen in Figure 2F and D, respectively). Moreover, no species was detected at m/z 475.2 and no mass additions of neither 42.0 nor 84.0 Da to the glycan were detected in an acetyltransferase lacking (pglI null) background (KS144) (Supplementary data, Fig. 2a and b). Thus, the O-acetyltransferase PglI is capable of attaching at least two acetyl groups to the Neisseria diNAcBac-Gal glycan. Two additional diNAcBac-based disaccharides have previously been described in Neisseria, diNAcBac-Glc and diNAcBac-GlcNAc (Børud et al. , 2014 . Our earlier work has shown a single acetylation of the diNAcBac-Glc glycan while no acetylation was reported for the diNAcBac-GlcNAc glycan (as this work was performed in pglI mutant backgrounds) (Børud et al. 2014) . To investigate if the di-acetylation is a general feature on diNAcBac-based disaccharides, we applied high mass resolution top-down ESI MS in combination with insource fragmentation and targeted CID/HCD fragmentation of different PilE proteins modified with either diNAcBac-Glc or the diNAcBac-GlcNAc-based disaccharides in backgrounds expressing PglI. The deconvoluted MS spectrum of PilE purified from the strain expressing diNAcBac-Glc-based disaccharide (KS352) showed protein species consistent with no acetylation (at m/z 17,691.2 and at m/z 17,814.2), mono-acetylation (at m/z 17,733.2 and at m/z 17,856.2) and diacetylation of the disaccharide (at m/z 17,775.2 and at m/z 17,898.2) ( Figure 2F ). In-source fragmentation revealed reporter ions consistent with no-(m/z 391.2), mono-(m/z 433.2) and di-acetylation (m/z 475.2) of the diNAcBac-Glc disaccharide ( Figure 2G ). The MS2 spectrum of the ion at m/z 475.2 ( Figure 2J ) showed a similar fragmentation pattern as the corresponding ions generated from the diNAcBac-Gal-based glycan (Figure 2E) , with the appearance of a di-acetylated Glc ion at m/z 247.1. Moreover, the MS2 spectrum resembled the previously reported diNAcBac-Glc ( Figure 2H ) and diNAcBac-AcGlc ( Figure 2I ) with an addition 42 Da located at the distal Glc sugar. No ion at m/z 475.2 or protein forms consistent with acetylation of diNAcBac-Glc was detected in the pglI mutant background (KS421) (Supplementary data, Figs. 2c and 2d) . The diNAcBac-Glc disaccharide may therefore be doubly acetylated at the distal Glc sugar. For the strain producing a diNAcBac-GlcNAc-based disaccharide (KS985), the same pattern of acetylation was observed as seen for the diNAcBac-Gal and the diNAcBac-Glc glycan. Species consistent with both single (at m/z 17,774.2 and at m/z 17,897.2) and double (at m/z 17,816.2 and at m/z 17,939.2) acetylation were detected ( Figure 2K ). The MS2 spectrum of the ion at m/z 474.2 ( Figure 2N ) (42.011 Da larger than the diNAcBac-GlcNAc precursor ion at m/z 432.197 ( Figure 2M) ) showed a fragment pattern consistent with a single acetylation of the distal GlcNAc sugar, with the appearance of the acetylated GlcNAc ion at m/z 246.1. Whereas the MS2 spectrum of the ion at m/z 516.2 ( Figure 2O ) (42.010 Da larger than the ion at m/z 474.208) showed a fragmentation pattern consistent with a double acetylation of the distal GlcNAc sugar. No ions indicative of mass additions of 42.0 or 84.0 to the diNAcBac-GlcNAc glycan in the pglI background (KS966) were detected (Supplementary data, Figs. 2e and 2f ). Thus, all known diNAcBacbased disaccharides, can be doubly acetylated by the O-acetyltransferase PglI.
Results

Acetylation of diNAcBac-based glycans
Acetylation of diNAcBac-based trisaccharides
The only glycosyltransferase in pathogenic Neisseria known to be capable of generating a trisaccharide glycoform is PglE. Although the number of possible acetylation sites increases on a trisaccharide, only a single PglI-dependent O-acetylation has been found for both trisaccharide glycoforms diNAcBac-Gal-Gal and GATDH-Gal-Gal (Aas et al. 2007; Børud et al. 2011) . Therefore, to investigate the number of O-acetylations present on the diNAcBac-Gal-Gal trisaccharide, we performed top-down MS of PilE from the KS142 strain (expressing an acetylated diNAcBac-Gal-Gal glycan). As shown in Figure 3A , the deconvoluted mass spectrum of PilE from the KS142 strain with the most abundant protein species at m/z 17,895. trisaccharide glycan modified protein species. The diNAcBac-Gal-Gal protein forms could be seen at m/z 17,853.1 and at m/z 17,976.1 whereas only small peaks at m/z 17,937.2 and at m/z 18,060.2, consistent with di-acetylated trisaccharide glycan modified protein species were detected. No peak representing a triply acetylated trisaccharide modified protein species was detected in the deconvoluted mass spectrum. The MS2 spectrum of the Ac-diNAcBac-Gal-Gal ion at m/z 595.2 from in-source fragmentation of PilE ( Figure 3B ) was consistent with previous data (Aas et al. 2007) showing only a loss of H 2 O (18.0 Da) or Gal (162.0 Da) from the 595.2 precursor ion to the m/z 433.2 mono-acetylated disaccharide ion. No ion representing diNAcBac-Gal (at m/z 391.2) was detected, demonstrating that for the mono-acetylated trisaccharide glycoform, the acetylation was primarily located at the first Gal (diNAcBac-AcGal-Gal). The low abundance of protein species corresponding to di-acetylated trisaccharide, yielding a reporter ion at m/z 637.2 from in-source fragmentation of PilE (Supplementary data, Fig. 3 ) when selectively fragmented, generated an MS2 spectrum close to the noise level ( Figure 3C ). The loss of 204.0 Da from the ion at m/z 637.2 to the diNAcBac-AcGal ion at m/z 433.2 indicated that for di-acetylated trisaccharide, the second acetylation may be located at the distal Gal residue (diNAcBac-AcGal-AcGal). However, the low abundance of glycan related fragment ions obscures any other combination of location for di-acetylation on the trisaccharide. No ion corresponding to a third acetylation of the diNAcBac-Gal-Gal was detected and only ions related to nonacetylated trisaccharide was detected in the KS304 pglI mutant strain (Supplementary data, Fig. 4a-d) . The di-acetylation of the diNAcBac-Gal-Gal trisaccharide is therefore dependent upon PglI and, since the distal Gal only gets acetylated when two acetylations are present, seems to be hierarchical. 
Acetylation of GATDH-based sugar
Acetylation of GATDH In addition to diNAcBac-based glycans, a second reducing end sugar, GATDH, has been described in Nm (Chamot-Rooke et al. 2007 ). Using an Ng strain expressing pglB2, previous work reported both GATDH-Gal and GADTH-Glc to be mono-acetylated ) while GATDH-GlcNAc was only characterized in a pglI mutant background (Børud et al. 2014) . To investigate the acetylation status of GATDHbased glycans, we performed top-down ESI MS analysis and in-source fragmentation of PilE from strains expressing PglI and GATDH-based glycans and targeted glycan reporter ions for HCD/CID MS2. In Figure 4A , the deconvoluted PilE mass spectrum from top-down ESI MS of PilE from the strain expressing only the GATDHmonosaccharide (KS309) showed two major protein species representing PilE with a single GATDH modification and either one PE (at m/z 17,575.1) or two PE (at m/z 17,698.1) modifications. Two peaks 42.0 Da larger than the major protein species, consistent with acetylated GADTH, were seen at m/z 17,617.1 (1 PE) and at m/z 17,740.1 (2 PE) ( Figure 4A ). To further investigate the acetylation status of GATDH, we targeted the reporter ion for GATDH, at m/z 275.123, and the reporter ion consistent with an acetylated GATDH, at m/z 317.133 ( Figure 4B ) for MS2 fragmentation. The MS2 spectrum of GATDH shown in Figure 4C was consistent with previously reported fragmentation spectrum of GATDH (Chamot-Rooke et al. 2007 ). The MS2 spectrum of the ion at m/z 317.1 ( Figure 4D ) showed a fragmentation pattern that, except for the 42.0 Da mass addition, followed the GATDH fragmentation pattern. Moreover, the two MS2 spectra converged at the m/z 257.1 ion (m/z 215.1 + 42.0 Da) and followed the same fragmentation pathway demonstrating that the core of the two molecules are the same. No ion consistent with two 42.0 Da mass additions to the GATDH glycan was detected and no ion at m/z 317.1 was detected in the acetylation negative pglI background (N60) (Supplementary data, Fig. 5 ). Thus, PglI is capable of attaching a single acetate moiety to the glyceracetamido group of GATDH.
Acetylation of GATDH-based di-and trisaccharide
When investigating the GATDH-based disaccharides, nonacetylated, acetylated and di-acetylated forms of GATDH-Gal (KS308) (Supplementary data, Fig. 6a-d) , GATDH-Glc (KS361) (Supplementary data, Fig. 6 e-h) and GATDH-GlcNAc (KS968) (Supplementary data, Fig. 6 i-l) were detected. MS2 spectra of mono-acetylated GATDH-Gal (Supplementary data, Fig. 6b ) and GATDH-Glc (Supplementary data, Fig. 6f ) (ions at m/z 479.2) as well as mono-acetylated GATDH-GlcNAc (Supplementary data, Fig. 6J ) (ion at m/z 520.2) showed fragment ions both at m/z 275.1 (GATDH) and at m/z 317.1 (AcGATDH). These results demonstrated that for the mono-acetylated GATDHbased disaccharides, there was a mix of glycoforms with acetylation either at the basal (GATDH) residue or on the distal (disaccharide) position. MS2 spectra of di-acetylated GATDH-Gal (Supplementary data,  Fig. 6c ) and GATDH-Glc (Supplementary data, Fig. 6g ) (ions at m/z 521.2) also showed ions at m/z 275.1 and at m/z 317.1 as well as at m/z 247 (2xAcHex) demonstrating that the di-acetylated glycoforms of GATDH-Gal and GATDH-Glc were a mix of AcGATDH-AcGal (AcGATDH-AcGlc) and the GATDH-diAcGal (GATDH-diAcGlc) glycoforms. However, no ion at m/z 275.1 was detected in MS2 spectra of di-acetylated GATDH-GlcNAc (Supplementary data, Fig. 6k ) (ion at m/z 562.2) indicating that only a single di-acetylated glycoform, AcGATDH-AcGlcNAc (strain KS968) was present. For the GATDHbased trisaccharide (GATDH-Gal-Gal, strain KS310), the deconvoluted mass spectra (Supplementary data, Fig. 6p ) showed abundant species consistent with a nonacetylated trisaccharide (mass addition of 598.2 Da, at m/z 17,777.1, at m/z 17,900.1 (1 PE) and at m/z 18,023.1 (2 PE)) as well as mono-acetylated trisaccharide (mass addition of 640.2 Da, at m/z 17,819.1, at m/z 17,942.1 (1 PE) and at m/z 18,065.1 (2 PE)). However, no mass consistent with a di-acetylated protein species could be unambiguously identified. In-source fragmentation (Supplementary data, Fig. 5m ) and targeted MS2 of the ion at m/z 641.2 (Supplementary data, Fig. 5n ) showed fragmentation patterns with ions at m/z 275.1 (GATDH), m/z 317.1(AcGATDH), m/z 437.2 (GATDH-Gal) and at m/z 479.2 (GATDH-AcGal). Both the presence and intensity of these ions demonstrated that all three residues of the GATDH-Gal-Gal glycan may be singly acetylated in the monoacetylated glycoform. Targeted MS2 of the ion at m/z 683.2 (Supplementary data, Fig. 5o ), consistent with a di-acetylated trisaccharide glycoform, produced a fragment pattern indicating that multiple overlapping precursor ions had been selected for fragmentation thereby preventing a clear results. However, in the small mass area, reporter ions consistent with AcGATDH (at m/z 317.1, at m/z 299.1, at m/z 257.2, and at m/z 215.1) show that there is a di-acetylated GATDH-Gal-Gal glycoform although at very low levels. No triacetylated glycoforms were detected for any of the GATDH-based dior trisaccharides. Moreover, no glycoforms consistent with a 42.0 Da mass addition were detected in O-acetyltransferase negative (pglI) backgrounds of GATDH-based glycoform expressing strains (KS901, KS420, KS970, KS414) (Supplementary data, Fig. 7) . PglI is therefore capable of modifying GATDH-based disaccharides with mono-and di-acetylation at the disaccharide position or a combination of monoacetylation of the disaccharide position with a single acetylation of GATDH. Moreover, PglI is capable of acetylating the GATDH-Gal-Gal glycan with a single acetyl group on all three sugar positions. 
Acetylation can influence glycan chain length elongation
When investigating the effect of O-acetylation on glycans from a strain simultaneously expressing both diNAcBac-Gal (PglA-based) and diNAcBac-GlcNAc (PglH2-based) glycoforms in pglI background, a previously undescribed glycoform was found. As seen in Figure 5A , the deconvoluted mass spectrum of PilE from this strain (KS983), showed signals corresponding to the protein modified with nonacetylated diNAcBac-Gal (together with 1 PE at m/z 17,691.2 and with 2 PE at m/z 17,814.2) and nonacetylated diNAcBac-GlcNAc (with 1 PE at m/z 17,732.2 and with 2 PE at m/z 17,855.2) glycoforms. Interestingly, two previously undescribed forms were detected at m/z 17,895.2 and at m/z 18,018.2 that correspond to a Table I . N. gonorrhoeae strains used in this study diNAcBac-GlcNAc Figure 5 and Supplementary data, Figure S8 diNAcBac-Gal diNAcBac-Gal-GlcNAc KS391 lct::pglH2 SK-93-1035 diNAcBac-GlcNAc Figure 5 and Supplementary data, Figure S8 diNAcBac-AcGlcNAc diNAcBac-diAcGlcNAc diNAcBac-AcGal diNAcBac-diAcGal RV710 pglE pglI::kan lct::pglH2 A303Q diNAcBac-Gal Figure 5 and Supplementary data, Figure S8 diNAcBac-GlcNAc diNAcBac-Gal-GlcNAc 593.2 Da protein modification in addition to 1 PE and 2 PE modifications, respectively. In-source fragmentation of PilE and targeted MS2 of the ion at m/z 594.2 (Supplementary data, Fig. 8a ) generated a fragmentation pattern consistent with a previously undescribed trisaccharide ( Figure 5B ). The 203.0 Da difference between the precursor ion at m/z 594.2 and the ion at m/z 391.2, together with the presence of the reporter ion at m/z 204.1 demonstrated that the distal moiety was HexNAc. The ion at m/z 391.2, 162.1 Da larger than the diNAcBAc ion (at m/z 229.1), corresponded to diNAcBac-Hex, showing that the second position of the trisaccharide was occupied by Gal. Moreover, the presence of only a single ion representing the second sugar at m/z 391.2 (diNAcBac-Gal) and not a combination of disaccharide ions at m/z 391.2 and at m/z 432.2 (diNAcBac-GlcNAc) indicated that PglA and PglH2 operate strictly sequentially, generating only a diNAcBac-Gal-HexNAc glycoform. In the low mass area, ions characteristic of diNAcBac fragmentation (at m/z 229.1, m/z 211.1 and at m/z 168.6) were detected. This is in contrast to our previous results from a strain expressing pilin from an otherwise isogenic strain containing an intact pglI allele ( Figure 5C ), where no 593.2 Da mass addition to PilE was detected (and thus no ion species at m/z 17,895.2 nor at m/z 18,010.2). Neither was a glycan reporter ion at m/z 594.28 detected by in-source fragmentation of PilE from strain KS391 (Supplementary data, Fig. 8b ) demonstrating that the presence of the diNAcBac-Gal-HexNAc trisaccharide was associated with the lack of glycan O-acetylation.
To further investigate the basis for the conditional expression of the unique trisaccharide, we exploited the availability of a strain expressing a pglH2-derived allele that leads to incorporation of Glc (rather than GlcNAc) at the second position (Børud et al. 2014) . This allele differs from that which incorporates GlcNAc by a single amino acid substitution at position 303 (alanine instead of glutamine). The deconvoluted mass spectrum derived from this background (RV710) yielded a single abundant diNAcBac-Hex form corresponding to a mixture of Glc and Gal glycoforms (at m/z 17,692.1 together with 1 PE and at m/z 17,815.1 together with 2 PE) ( Figure 5D ). That is, no species consistent with a trisaccharide or a HexNAc containing glycoform were detected. (Figure 5D and Supplementary data, Fig 8c) . The trisaccharide glycoform is therefore specifically associated with the GlcNAc-incorporating PglH2 glycosyltransferase.
Discussion
The O-acetylation of bacterial surface glycoconjugates such as CPS and O-specific polysaccharides of LPS often has profound consequences for glycan structure and immunochemistry. In such instances, differential phenotypes almost invariably reflect the simple presence or absence of O-acetate on an otherwise unmodified glycan structure.
In this report, we confirm and extend our understanding of Oacetylation in the pgl systems of Ng and Nm. In concordance with our previous data, we found no evidence for PglI impacting on diNAcBac structure or biosynthesis. Likewise, clear evidence was seen for O-acetylation of the Gal residue (associated with pglA) as well as the Glc residue (associated with pglH) in both diNAcBac-and GATDH-based disaccharides. For the first time, we demonstrated that the GlcNAc residue (associated with pglH2) in both diNAcBacand GATDH-based disaccharides also undergo O-acetylation. Similarly, there is now clear evidence that the Gal, Glc and GlcNAc residues in disaccharides were also susceptible to being modified with two acetate groups. In addition, the MS data here revealed the previously unrecognized O-acetylation of the distal Gal residue in both diNAcBac-and GATDH-based trisaccharides. It is noteworthy that the levels of O-acetylation of the distal Gal in the trisaccharides, although detectable, were relatively low and that in diNAcBac-based trisaccharide such modifications were only seen on glycoforms in which the central Gal residue was also O-acetylated. These findings may be indicative of a hierarchical mode of O-acetylation in which modification of the third residue relies on modification of the second residue. Another finding of note is the presence of O-acetate on the basal GATDH residue.
Perhaps the most striking findings involve the genetic interactions observed between pglA, pglH2 and pglI. Strains expressing both PglA and PglH2 together with PglI expressed mixtures of disaccharide forms carrying O-acetylated Gal and O-acetylated GlcNAc at the nonreducing ends. In a pglI null background, an unanticipated and prominent reporter ion was detected together with those corresponding to the expected nonacetate modified disaccharides. CID/HCD MS2 and further fragmentation analysis of this unique reporter ion at m/z 594.2 defined it as corresponding to a diNAcBac-Gal-HexNAc trisaccharide. Thus, PglI expression and glycan O-acetylation are associated with altered oligosaccharide chain length.
In determining how O-acetylation might exert its impact here, we envision two basic possibilities based on knowledge of the pgl biosynthetic pathway ) (illustrated in Figure 6 ). In one scenario, the unique UndPP-trisaccharide in its O-acetylated form would be synthesized but is incompatible with downstream events. These would be the penultimate and final steps in the pathway entailing flipping of the UndPP-glycoform into the periplasm (Figure 6 (2)) and its use as a donor substrate by PglO (Figure 6(3) ), the protein targeting oligosaccharyltransferase respectively. However, both neisserial flippases in general and the neisserial PglO oligosaccharyltransferase specifically are very promiscuous in substrate utilization (Aas et al. 2007; Faridmoayer et al. 2008) . In fact, both steps clearly accommodate a large array of glycoforms in their O-acetylated and nonacetylated forms. A more favored scenario then is that Oacetylation of the UndPP-diNAcBac-Gal disaccharide blocks its further elaboration by a glycosyltransferase (Figure 6(1) ). Given the dependence of this phenomenon on PglH2 (and not PglH), it seems possible that PglH2 has two activities: one that adds GlcNAc to UndPP-diNAcBac and a second that adds a HexNAc to the UndPP-diNAcBac-Gal. This latter activity would be inhibited by O-acetylation of the UndPP-disaccharide acceptor and thus only detected in a pglI background.
The latter model has potentially significant implications for Oacetylation mechanisms of bacterial glycans destined ultimately to an extracytoplasmic location. In perhaps the best studied system involving PG, O-acetylation is generally thought to occur in the periplasm (Moynihan et al. 2014 ). There, translocation of donor acetate groups from the cytoplasm (acetyl-CoA being the presumed source) to the periplasm is thought to be carried out by an integral membrane protein, PatA or homologs thereof. Subsequent transfer to PG is then carried out by PatB, a peripheral membrane O-acetyltransferase. In Gram-positive bacteria, a single composite membrane protein, OatA, is proposed to catalyze both reactions of the process. The situation with regard to LPS O-acetylation remains less clear. PglI shows clear structural similarities to other predicted O-acetylases with the Acyl_transf_3-Pfam PF01757 domain and multiple membrane spanning elements implicated in LPS modifications. Few if any biochemical or enzymatic parameters have been defined for any of them. Assuming that PglI-mediated acetate addition blocks oligosaccharide chain elongation (as opposed to blocking downstream UndPP oligosaccharide processing) and given the fact that oligosaccharide chain extension takes place in the cytoplasm, it stands to reason that O-acetylation also takes place on the cytoplasmic side of the inner membrane in this system. Whether this finding can be extended to LPS-related processes remains to be determined. Nonetheless, the cytoplasmic partitioning of this process would be consistent with the absence of any identifiable acetyl-CoA translocating element within the neisserial pgl and LPS systems.
We are aware of only one other example of an association between O-acetylation and glycan chain elongation. This occurs in association with cell wall biosynthesis in N. meningitidis where de-O-acetylation of specific PG muropeptides impacts on glycan chain elongation (Veyrier et al. 2013) . In contrast to the situation with pgl glycoform acetylation, the absence of O-acetylation (mediated by the action of Ape1, a deacetylase) is associated with glycan chain elongation (truncation) whereas in our case O-acetylation blocks glycan extension.
Together, these results reveal heretofore unrecognized levels of complexity and microheterogeneity of pgl glycoform O-acetylation. Moreover, the finding that O-acetylation impacts on oligosaccharide chain length is noteworthy in that pglI expression in Nm (but not in Ng) is subject to phase-variable expression. Thus on-off PglI expression in Nm would result not only in shifts between oligosaccharides with or without acetate modification but also in the basic repertoires of oligosaccharides and the levels of glycoform microheterogeneity. Further studies are required to discern the precise mechanisms by which O-acetylation modify oligosaccharide chain length in this system.
Materials and methods
Bacterial strains and culture conditions All bacterial strains used in this study are Ng, described in Table I , and were grown on conventional GC medium as previously described .
Construction of pgl mutants pgl mutations (pglA, pglEon, pglI, pglH, pglH2, pglB2) were introduced into various strain backgrounds using transformation of constructs as detailed in Table I and previously described (Aas et al. 2006 (Aas et al. , 2007 Børud et al. 2010 Børud et al. , 2011 . Antibiotics were used for selection of transformants at the following concentrations: streptomycin, 750 μg mL -1 ; erythromycin, 8 μg mL -1 ; kanamycin, 50 μg mL -1 ; gradient chloramphenicol, 25 μg ml -1 . The pglE mutation was made by deletion of the HinfI fragment of pglE (549 bp) in the pCRII-pglE plasmid, this deletion was spot transformed into the pglE gene in the N400 background, and correct pglE deletion strains were screened and confirmed by PCR.
Sample preparation and top-down MS analysis of intact protein
PilE purification, sample preparation and top-down ESI-MS on the LTQ Orbitrap were performed as previously described (Vik et al. 2012) . Intact protein mass spectra were acquired with a resolution of 60 000 at m/z 400. Deconvoluted protein masses are reported as monopronated [M+H+] . Masses of unmodified and modified proteins were determined from calculated theoretical masses, mass differences and previous work. Masses and reporter ions of PilE PTM modifications are reported in Table II . Relevant m/z values of modified PilE species are reported in Table III. 
